Billionaire Dr. Patrick Soon-Shiong’s company acquires majority stake in Integrity Healthcare
(By Alyssa Rege for Becker’s Hospital Review) Patrick Soon-Shiong, MD, and his company NantWorks, acquired a majority stake in Boynton
Read More
Month: July 2017
Personalized cancer vaccines vanquish melanoma in small but encouraging study
(By Sharon Begley for ST A T) A small pilot study raises hopes that personalized cancer vaccines might prove safer
Read MoreTo solve organ shortage, states consider ‘opt-out’ organ donation laws
(By Leah Samuel for ST A T) T he shortage of organs for transplantation is a thorny problem. Nearly 118,000
Read MoreNew Model for Classifying Cancer Patients Could Lead to Better End-of-Life Care
Harvard Medical School researchers found Medicare’s policies governing cancer patient’s end-of-life care are based on generalized statistics often fail to
Read MoreCorporate Whistleblower Center Urging Doctors to Call Them About Violations of Medicare’s False Claims Act
Prompted by a Justice Department announcement in June that Genesis Healthcare would pay the federal government more than $53.6 million
Read MoreAs new and lethal opioids flood U.S. streets, crime labs race to identify them
(By Max Blau for ST A T) ATLANTA — The yellow pills had already killed four before landing in Brian
Read MoreThe Price of Two Cancer Drugs Were Raised for the Second Time this Year
Amgen Inc. and Teva Pharmaceutical Industries have raised the price of their cancer drugs (Blincyto and Treanda, respectively) last week
Read MoreSecond Sight (EYES) Announces Expansion Of Medicare Coverage For Argus II Retinal Prosthesis System To 11 Additional States And The District Of Columbia
Argus II Can Now Be Covered in Seven of 12 Medicare Administrative Contractor Jurisdictions, representing a total of 28 states,
Read MoreAs Seniors Get Sicker, They’re More Likely To Drop Medicare Advantage Plans
(By Fred Schulte for NPR) When Sol Shipotow enrolled in a new Medicare Advantage health plan earlier this year, he
Read More23andMe: Direct to Consumer Genetic Test without Prescription
23andMe, the first company to win approval from the FDA to sell “direct to consumer” genetic test for five diseases
Read More